BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Protalix Biotherapeutics, Inc. 

2 Snunit St.
Science Park
Carmiel      Israel
Phone: 972-4-9028100 Fax: 972-4-988-9489


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Protalix Biotherapeutics, Inc. (PLX)' Technology Transfer Agreement For UPLYSO™ (Alfataliglicerase) With Brazil's Ministry Of Health Approved By The Brazilian National Institute Of Industrial Property 2/6/2014 9:30:49 AM    More...
Protalix Biotherapeutics, Inc. (PLX) Signs $280 Million Brazilian Gaucher Deal 6/19/2013 7:35:13 AM    More...
Protalix Biotherapeutics, Inc. (PLX) to Present at the Oppenheimer 14th Annual Israeli Conference 5/8/2013 9:29:09 AM    More...
Protalix Biotherapeutics, Inc. (PLX) Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease 4/2/2013 11:39:12 AM    More...
Protalix Biotherapeutics, Inc. (PLX) Signs $8.3 Million Deal With Pfizer Inc. (PFE) to Continue Managing Elelyso Trials 12/6/2012 7:14:17 AM    More...
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX)'s Gaucher Drug Rejected by EU Regulator 6/22/2012 8:29:05 AM    More...
Protalix Biotherapeutics, Inc. (PLX) Announces Closing of Public Offering and Exercise of Over-Allotment Option 2/22/2012 2:19:02 PM    More...
Protalix Biotherapeutics, Inc. (PLX) Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium 1/26/2012 9:24:18 AM    More...
Protalix Biotherapeutics, Inc. (PLX) Announces Successful European GMP Audit 12/1/2011 12:16:22 PM    More...
Protalix Biotherapeutics, Inc. (PLX) to Present at the UBS Global Life Sciences Conference 9/13/2011 12:04:41 PM    More...
12

//-->